Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
Proinflammatory cytokines are potent mediators of numerous biological processes and are tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and derive many pathologies, including incidences of autoimmunity and cancer. Therefore, therapies that regulate the activ...
Saved in:
| Main Authors: | Peleg Rider, Yaron Carmi, Idan Cohen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Cell Biology |
| Online Access: | http://dx.doi.org/10.1155/2016/9259646 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting γc family cytokines with biologics: current status and future prospects
by: Fabian Bick, et al.
Published: (2025-12-01) -
Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
by: Simonetta I. Gaumond, et al.
Published: (2025-04-01) -
Inflammatory Cytokines in Diabetic Nephropathy
by: Javier Donate-Correa, et al.
Published: (2015-01-01) -
Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice
by: Leticia Leon, et al.
Published: (2025-03-01) -
The protective effect of biologic and targeted-synthetic therapies on developing multisystem inflammatory syndrome in children
by: Lana Khoury, et al.
Published: (2025-07-01)